MedinCell S.A. (EPA:MEDCL)
France flag France · Delayed Price · Currency is EUR
26.22
+0.34 (1.31%)
Oct 22, 2026, 5:35 PM CEST

MedinCell Revenue

In the fiscal year ending March 31, 2026, MedinCell had annual revenue of 19.52M EUR, down -23.21%. MedinCell had revenue of 7.91M in the half year ending March 31, 2026, with 286.42% growth. That makes MedinCell the 31,973rd largest company in the world by revenue and 405th in France.

Revenue
19.52M
Revenue Growth
-23.21%
P/S Ratio
38.79
Revenue / Employee
172.18K
Employees
141
Market Cap
941.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202619.52M-5.90M-23.21%
Mar 31, 202525.42M16.39M181.43%
Mar 31, 20249.03M-857.00K-8.67%
Mar 31, 20239.89M1.55M18.60%
Mar 31, 20228.34M152.00K1.86%
Mar 31, 20218.19M5.33M187.03%
Mar 31, 20202.85M1.41M97.78%
Mar 31, 20191.44M-5.00M-77.61%
Mar 31, 20186.44M-2.09M-24.54%
Mar 31, 20178.53M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE142.94M
Genfit59.49M
Cellectis55.86M
Nanobiotix11.51M
Innate Pharma9.81M
Sensorion6.16M
Transgene5.62M
Valerio Therapeutics Société anonyme5.55M
Revenue Rankings